Table 2.
No Exercise
|
Exercise
|
|||
---|---|---|---|---|
Placebo | Testosterone | Placebo | Testosterone | |
Testosterone, nmol/L†‡ | ||||
Baseline | 6.1 (0.7) | 7.1 (0.8) | 7.0 (1.0) | 7.0 (1.2) |
| ||||
Week 16 | 5.0 (0.5) | 11.7 (1.6) | 7.4 (1.2) | 10.8 (1.9) |
| ||||
Change from baseline | −1.2 (0.6) | 4.5 (1.8)§ | 0.4 (1.0) | 3.8 (2.1)§ |
| ||||
P value | .06 | .03 | .62 | .05 |
| ||||
Free testosterone, pmol/L†‡ | ||||
Baseline | 100.5 (13.9) | 111.0 (13.9) | 117.9 (17.3) | 93.6 (13.9) |
| ||||
Week 16 | 107.5 (20.8) | 183.8 (24.2) | 121.4 (13.9) | 166.4 (20.8) |
| ||||
Change from baseline | 1.0 (24.2) | 72.8 (27.7) | 3.5 (13.9) | 69.3 (20.8) |
| ||||
P value | .70 | .02 | .57 | .02 |
| ||||
Luteinizing hormone, U/L|| | ||||
Baseline | 5.0 (1.0) | 3.4 (0.4) | 4.3 (0.9) | 6.6 (2.0) |
| ||||
Week 16 | 3.7 (0.8) | 0.3 (0.1) | 4.6 (1.0) | 0.6 (0.3) |
| ||||
Change from baseline | −1.4 (0.7) | −3.1 (0.4)§ | 0.3 (0.2) | −6.0 (1.8)§ |
| ||||
P value | .17 | ,.001 | .39 | ,.001 |
| ||||
Follicle-stimulating hormone, U/L|| | ||||
Baseline | 5.8 (1.8) | 4.5 (0.5) | 7.1 (1.9) | 8.6 (2.6) |
| ||||
Week 16 | 5.0 (2.0) | 0.5 (0.2) | 6.7 (1.6) | 2.0 (1.2) |
| ||||
Change from baseline | −0.8 (0.8) | −4.2 (0.4)¶ | −0.4 (0.7) | −6.5 (1.6)¶ |
| ||||
P value | .20 | ,.001 | .71 | ,.001 |
| ||||
Sex hormone–binding globulin, nmol/L | ||||
Baseline | 66.4 (12.1) | 48.6 (8.8) | 52.0 (12.9) | 47.5 (8.3) |
| ||||
Week 16 | 63.7 (16.8) | 41.7 (7.0) | 49.1 (9.5) | 41.7 (8.9) |
| ||||
Change from baseline | −2.7 (8.3) | −6.9 (3.1) | −2.9 (3.8) | −5.8 (2.4) |
| ||||
P value | .75 | .05 | .46 | .05 |
The data represent the mean (SEM) of all available values on that day. However, the change represents the difference between paired values only.
Overall analysis of variance is P<.03.
To convert total testosterone levels to nanograms per deciliter, multiply by 28.843. To convert free testosterone levels to picograms per milliliter, multiply by 0.28843.
P<.05 vs placebo, no exercise.
Overall analysis of variance, P<.001.
P<.05 vs placebo, no exercise, and placebo with exercise.